A detailed history of Essex Investment Management CO LLC transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Essex Investment Management CO LLC holds 336,722 shares of DCTH stock, worth $3.29 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
336,722
Previous 335,903 0.24%
Holding current value
$3.29 Million
Previous $2.81 Million 8.15%
% of portfolio
0.57%
Previous 0.56%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$7.36 - $11.0 $6,027 - $9,009
819 Added 0.24%
336,722 $3.04 Million
Q2 2024

Aug 12, 2024

BUY
$4.47 - $8.37 $1.5 Million - $2.81 Million
335,903 New
335,903 $2.81 Million

Others Institutions Holding DCTH

About DELCATH SYSTEMS, INC.


  • Ticker DCTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 8,597,680
  • Market Cap $83.9M
  • Description
  • Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...
More about DCTH
Track This Portfolio

Track Essex Investment Management CO LLC Portfolio

Follow Essex Investment Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex Investment Management CO LLC with notifications on news.